Case Report: Fatal pneumonitis caused by Camrelizumab and Erlotinib in a patient with metastatic pancreatic cancer - Top-Institutions - MDSpire

Case Report: Fatal pneumonitis caused by Camrelizumab and Erlotinib in a patient with metastatic pancreatic cancer

  • By

  • Yanyan Jiang

  • Lihong Ma

  • Bei Lu

  • Wei Tian

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Johns Hopkins Sidney Kimmel Cancer Center
    Johns Hopkins Sidney Kimmel Cancer Center

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #4

    Cleveland Clinic Lerner College of Medicine
    Cleveland Clinic Lerner College of Medicine

    Cleveland, Ohio

    Key Differentiators

    • Oncology

  • #5

    Netherlands Cancer Institute
    Netherlands Cancer Institute

    Amsterdam, North Holland

    Key Differentiators

    • Oncology

Original Source(s)

Case Report: Fatal pneumonitis caused by Camrelizumab and Erlotinib in a patient with metastatic pancreatic cancer

  • by Yanyan Jiang, Lihong Ma, Bei Lu, Wei Tian

  • June 10, 2026

Related Content

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma